IL149243A0 - Tetrapeptide-l-alanyl-l-glutamyl-l-aspartyl-l-proline and its salts and pharmaceutical compositions containing the same - Google Patents

Tetrapeptide-l-alanyl-l-glutamyl-l-aspartyl-l-proline and its salts and pharmaceutical compositions containing the same

Info

Publication number
IL149243A0
IL149243A0 IL14924300A IL14924300A IL149243A0 IL 149243 A0 IL149243 A0 IL 149243A0 IL 14924300 A IL14924300 A IL 14924300A IL 14924300 A IL14924300 A IL 14924300A IL 149243 A0 IL149243 A0 IL 149243A0
Authority
IL
Israel
Prior art keywords
salts
tetrapeptide
proposed
neurones
glu
Prior art date
Application number
IL14924300A
Other languages
English (en)
Original Assignee
Sankt Peterburgskaya Obschestv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankt Peterburgskaya Obschestv filed Critical Sankt Peterburgskaya Obschestv
Publication of IL149243A0 publication Critical patent/IL149243A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL14924300A 1999-10-20 2000-05-25 Tetrapeptide-l-alanyl-l-glutamyl-l-aspartyl-l-proline and its salts and pharmaceutical compositions containing the same IL149243A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU99121778/14A RU2155063C1 (ru) 1999-10-20 1999-10-20 Тетрапептид, стимулирующий функциональную активность нейронов, фармакологическое средство на его основе и способ его применения
PCT/RU2000/000218 WO2001029067A1 (en) 1999-10-20 2000-05-25 Tetrapeptide stimulating functional activity of neurones, pharmacological agent based thereon and method of use thereof

Publications (1)

Publication Number Publication Date
IL149243A0 true IL149243A0 (en) 2002-11-10

Family

ID=20225904

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14924300A IL149243A0 (en) 1999-10-20 2000-05-25 Tetrapeptide-l-alanyl-l-glutamyl-l-aspartyl-l-proline and its salts and pharmaceutical compositions containing the same

Country Status (10)

Country Link
US (1) US7189701B1 (xx)
EP (1) EP1224212B1 (xx)
JP (1) JP4668497B2 (xx)
AT (1) ATE244727T1 (xx)
AU (1) AU784578B2 (xx)
CA (1) CA2388357A1 (xx)
DE (1) DE60003837T2 (xx)
IL (1) IL149243A0 (xx)
RU (1) RU2155063C1 (xx)
WO (1) WO2001029067A1 (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7175679B2 (en) 2001-03-29 2007-02-13 Biotempt B.V. Oligopeptide treatment of NF-κB mediated inflammation
US6844315B2 (en) 1998-05-20 2005-01-18 Erasmus Universiteit Rotterdam Immunoregulator
US20030220258A1 (en) 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
EP1138692A1 (en) 2000-03-29 2001-10-04 Erasmus Universiteit Rotterdam Fragments of human chorionic gonadotropin (hcg) as immunoregulator
US8680059B2 (en) 1998-05-20 2014-03-25 Biotempt B.V. Oligopeptide acetate and formulations thereof
US6921751B1 (en) 1998-05-20 2005-07-26 Erasmus Universiteit Rotterdam Immunoregulator
USRE43279E1 (en) 2000-03-29 2012-03-27 Biotemp B.V. Compositions capable of reducing elevated blood urea concentration
EP1300418A1 (en) 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Gene regulation by oligopeptides
US7358330B2 (en) 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
US7576174B2 (en) 2000-03-29 2009-08-18 Biotempt B.V. Compositions capable of reducing elevated blood urea concentration
RU2161501C1 (ru) * 2000-06-29 2001-01-10 Санкт-Петербургская Общественная Организация "Санкт-Петербургский Институт Биорегуляции И Геронтологии Сзо Рамн" Способ получения пептидов, обладающих тканеспецифической активностью, и фармацевтические композиции на их основе
RU2238938C2 (ru) * 2001-05-24 2004-10-27 Пятигорская государственная фармацевтическая академия Производное имидазо-[1,2-а]-бензимидазола - средство, оказывающее церебропротекторное действие при радиационных поражениях
RU2224528C2 (ru) * 2001-07-24 2004-02-27 Брянский государственный университет им. акад. И.Г. Петровского Способ получения биологически активных пептидов каудальной нейросекреторной системы (кнсс) позвоночных
US7351686B2 (en) * 2001-12-06 2008-04-01 Yeda Research And Development Co. Ltd. Method for neuronal protection in amyotrophic lateral sclerosis by a vaccine comprising Copolymer-1 or Copolymer-1 related peptides
US7786084B2 (en) 2001-12-21 2010-08-31 Biotempt B.V. Treatment of burns
US7560433B2 (en) 2001-12-21 2009-07-14 Biotempt B.V. Treatment of multiple sclerosis (MS)
US7501391B2 (en) 2001-12-21 2009-03-10 Biotempt B.V. Treatment of transplant survival
RU2236857C2 (ru) * 2002-10-11 2004-09-27 Яско Анатолий Константинович Способ лечения атрофии мозга, гидроцефалии мозга препаратом ветом-7048
RU2244928C2 (ru) * 2003-02-19 2005-01-20 Пинигина Нина Максимовна Эндогенная фармацевтическая композиция, полученная на основе целенаправленной активации гуморальных медиаторов нервных окончаний коры головного мозга
JP4846799B2 (ja) 2005-07-05 2011-12-28 バイオテンプト ベー.フェー. 腫瘍の治療
EP1864692A1 (en) 2006-06-07 2007-12-12 Biotempt B.V. Use of peptides for the control of radiation injury
EP1857463A1 (en) 2006-05-03 2007-11-21 Ebewe Pharma Ges.m.b.H. Nfg. KG Peptide having neuroprotective effects
RU2301678C1 (ru) * 2006-05-30 2007-06-27 Общество С Ограниченной Ответственностью "Сиа Пептайдс" Пептид, стимулирующий регенерацию нейронов центральной нервной системы, фармацевтическая композиция на его основе и способ ее применения
EP2000134A1 (en) * 2007-06-06 2008-12-10 Neuraxo Biopharmaceuticals GmbH Use of a substance for the improvement of pns lesions
RU2362580C1 (ru) * 2007-11-07 2009-07-27 Федеральное государственное учреждение "Новокузнецкий научно-практический центр медико-социальной экспертизы и реабилитации инвалидов Федерального агентства по здравоохранению и социальному развитию" (ФГУ ННПЦ МСЭ и РИ Росздрава) Способ лечения спастического и болевого синдромов у пациентов с последствиями позвоночно-спинномозговой травмы
US9265458B2 (en) 2012-12-04 2016-02-23 Sync-Think, Inc. Application of smooth pursuit cognitive testing paradigms to clinical drug development
EA020866B1 (ru) 2013-02-28 2015-02-27 Замертон Холдингс Лимитед Пептиды с цитопротекторной активностью и фармацевтическая композиция
US9380976B2 (en) 2013-03-11 2016-07-05 Sync-Think, Inc. Optical neuroinformatics
EP3914280B1 (en) * 2019-01-25 2024-03-27 The Board of Regents of The University of Texas System Novel non-opioid anti-pain medication
RU2768475C1 (ru) * 2021-07-08 2022-03-24 Общество с ограниченной ответственностью "ТЕРРАНОВА КАПИТАЛ" Пептид, обладающий нейростимулирующей активностью и восстанавливающий способность к обучению и формированию памяти, фармацевтическая композиция на его основе и способ ее применения

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1623166A1 (ru) * 1989-04-03 1994-02-15 Институт биоорганической химии АН БССР Нейтропептиды, обладающие поведенческой активностью
WO1991009051A1 (en) * 1989-12-15 1991-06-27 G.D. Searle & Co. Substituted cyclic penicillanic acid tetrapeptides
US5652334A (en) * 1993-09-08 1997-07-29 City Of Hope Method for design of substances that enhance memory and improve the quality of life

Also Published As

Publication number Publication date
DE60003837T2 (de) 2004-06-03
US7189701B1 (en) 2007-03-13
EP1224212A1 (en) 2002-07-24
AU5258500A (en) 2001-04-30
AU784578B2 (en) 2006-05-04
DE60003837D1 (de) 2003-08-14
ATE244727T1 (de) 2003-07-15
RU2155063C1 (ru) 2000-08-27
CA2388357A1 (en) 2001-04-26
EP1224212B1 (en) 2003-07-09
JP4668497B2 (ja) 2011-04-13
WO2001029067A1 (en) 2001-04-26
JP2003532630A (ja) 2003-11-05

Similar Documents

Publication Publication Date Title
DE60003837D1 (de) Tetrapeptid, das die funktionelle aktivität von neuronen stimuliert, dieses enthaltendes pharmakologisches mittel und seine verwendung
IL146432A0 (en) A tetrapeptide and a pharmaceutical composition containing the same
ATE424810T1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
NO20043871L (no) Legemiddelformuleringer med kontrollert frigjoring som inneholder et baererpeptid
RU2005115855A (ru) Композиция трамадола продлонгированного высвобождением с 24-часовым действием
MY128014A (en) Thiol and thiocarbonyl derivatives which are useful as carboxypeptidase u inhibitors
TR200101633T2 (tr) Farmasötik bileşim
ES2217534T3 (es) Composicion farmaceutica para tratar la enfermedad de parkinson o la depresion.
TR200000752T2 (tr) Etkin terkibin kontrollü salınımı için ilaç formülü.
IL194500A0 (en) Peptide substance enhancing capillaries resistance, pharmaceutical composition on its base and method of its application
PT1027053E (pt) Metodo de prevencao de nefrotoxicidade provocada por ciclosporinas e tacrolimus
JP3470901B2 (ja) Elf5A生合成の抑制方法
CA2425445A1 (en) Tetrapeptide stimulating functional activity of hepatocytes, pharmacological substance on its basis and the method of its application
AU3231901A (en) Phenoxyalkylamine derivatives useful as opioid delta receptor agonists
SE9901572D0 (sv) New compounds
DK2032595T3 (da) Peptidsubstans, som har en immuno-gerobeskyttende virkning, farmaceutisk præparat på basis heraf og fremgangsmåde til anvendelse heraf
CA2382654A1 (en) Novel a-500359 derivatives
ES2010435A6 (es) Metodo para preparar preventivos y remedios para el envenenamiento medicinal y alcoholico.
MY122570A (en) Benzamide derivatives and drugs containing the same
RU99112967A (ru) Способ лечения и профилактики дизентерии свиней
NZ505080A (en) Pharmaceutical formulations containing a compound having an amidine group stabilized by an acid
CA2499620A1 (en) External preparation containing acetylsalicylic acid for inhibiting keloid formation
NO20013480D0 (no) Legemiddel for törr hud
GB1420976A (en) Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children
TH59380A (th) อนุพันธ์ของเบนซามีด และยาซึ่งมีสารชนิดเดียวกันนี้อยู่ด้วย